[February 09, 2016]

Global Hypertension Pipeline Review 2015 - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/svz5tn/hypertension) has announced the addition of the "Hypertension - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypertension and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Hypertension Overview
3. Therapeutis Development
4. Pipeline Products for Hypertension - Overview
5. Pipeline Products for Hypertension - Comparative Analysis
6. Hypertension - Therapeutics under Development by Companies
7. Hypertension - Therapeutics under Investigation by Universities/Institutes
8. Hypertension - Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Hypertension - Products under Development by Companies
13. Hypertension - Products under Investigation by Universities/Institutes
14. Hypertension - Companies Involved in Therapeutics Development

• A1M Pharma AB
• AbbVie Inc.
• Ache Laboratorios Farmaceuticos S/A
• Actelion Ltd
• Carolus Therapeutics, Inc.
• Cellceutix Corporation
• DiaMedica Inc.
• Hanmi Pharmaceuticals, Co. Ltd.
• Innopharmax Inc.
• Insmed Incorporated
• IntelGenx Corp.
• Intercept Pharmaceuticals, Inc.
• Ionis Pharmaceuticals, Inc.
• Jeil Pharmaceutical Co., Ltd.
• Jiangsu Hansoh Pharmaceutical Co., Ltd.
• Jiangsu Hengrui Medicine Co., Ltd.
• JW Pharmaceutical Corporation
• Kowa Company, Ltd.
• Lacer, S.A.
• Nippon Kayaku Co., Ltd.
• Nippon Shinyaku Co., Ltd.
• Novartis AG
• Noxamet Ltd
• Omeros Corporation
• Ono Pharmaceutical Co., Ltd.
• Peloton Therapeutics, Inc.
• Pfizer Inc.
• Sihuan Pharmaceutical Holdings Group Ltd.
• Silence Therapeutics Plc
• VBS Pharmaceuticals
• Vectura Group Plc
• VG Life Sciences, Inc.
• Vicore Pharma AB
• Yuhan Corporation

View source version on businesswire.com: http://www.businesswire.com/news/home/20160209006486/en/

[ Back To TMCnet.com's Homepage ]